Apellis Pharmaceuticals (APLS) PT Raised to $20 at Mizuho
Tweet
Share
E-mailGet Alerts APLS Hot Sheet
Price: $41.03 --0%
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 20 | New: 69
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 20 | New: 69
Join SI Premium – FREE
Mizuho analyst Graig Suvannavejh raised the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $20.00 (from $19.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Lantronix, Inc. (LTRX) PT Raised to $11 at Canaccord
- Mullen Group (MTL:CN) (MLLGF) PT Raised to Cdn$25 at BMO Capital
- WSP Global Inc. (WSP:CN) (WSPOF) PT Lowered to Cdn$266 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
